INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

82,081 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
LT
Lovalekar TusharVP, Information Technology
KOPKoppers Holdings Inc.
Option exercise
M—
85 sh
Jan 5, 2026Jan 6, 2026
Page 1773 of 2053
← PrevNext →
traded Jan 5, 2026
+1d
SEC Form 4

Evidence

9
AV
Altamura Michelle VervaisEVP, General Counsel, Sec.
IRMIRON MOUNTAIN INC
Option exercise
M—
1,214 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
LT
Lovalekar TusharVP, Information Technology
KOPKoppers Holdings Inc.
Grant or award
A—
316 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
BB
Bunker Mathew BSENIOR VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Grant or award
A—
68 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
SE
Sparks Paul EugeneDirector
BWINBaldwin Insurance Group, Inc.
Grant or award
A—
18.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
RP
Rayphole Robert P.VP CAO & Controller
APAAPA Corp
Tax withholding
F$8,166
322 sh
Jan 4, 2026Jan 6, 2026
traded Jan 4, 2026
+2dSEC Form 4

Evidence

9
DS
Duty StuartDirector
EYPTEyePoint, Inc.
Grant or award
A—
40.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
XY
Xia YuDirector
SMMTSummit Therapeutics Inc.
Grant or award
A—
35.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
KR
Krawczyk Joseph R IISR. VP, WW CLIENT ENGAGEMENT
MCHPMICROCHIP TECHNOLOGY INC
Grant or award
A—
1,730 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
PY
Park Angie YChief Financial Officer
ACNAccenture plc
Grant or award
A$28K
105 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

9
MH
Manji HusseiniDirector
ANROAlto Neuroscience, Inc.
Grant or award
A$50K
4,228 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
KR
Krawczyk Joseph R IISR. VP, WW CLIENT ENGAGEMENT
MCHPMICROCHIP TECHNOLOGY INC
Grant or award
A—
1,730 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
TH
Tunnicliff Max HughesCFO and Senior EVP
FASTFASTENAL CO
Grant or award
A—
28.8K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
HJ
Heitz Michael JohnChief Financial Officer
PRSUPursuit Attractions & Hospitality, Inc.
Tax withholding
F$14K
414 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
AJ
Arntzen Christopher JSVP, GC & Secretary
CABOCable One, Inc.
Grant or award
A—
7,488 sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

9
BM
Barrocas MarkDirector, Chief Executive Officer
SNSharkNinja, Inc.
Grant or award
A—
158.8K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

8
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
177 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

8
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$33K
161 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

8
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
86 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

8
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$10K
52 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

7
LM
Lin MarkEVP and CFO
SMTCSEMTECH CORP
Option exercise · 10b5-1 plan
M—
3,164 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

7
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$381K
1,659 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

7
SV
Singh VikasEVP & Chief Financial Officer
HCSGHEALTHCARE SERVICES GROUP INC
Option exercise · 10b5-1 plan
M—
3,980 sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

7
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$295K
1,292 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

6
LM
Lin MarkEVP and CFO
SMTCSEMTECH CORP
Tax withholding · 10b5-1 plan
F$88K
1,198 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

6
SN
Sieffert Kristen NPresident
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$18K
750 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

5
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Grant or award
A—
85.7K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

5
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise
M—
19.7K sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

5
OS
Olsson ShawnChief Commercial Officer
LENZLENZ Therapeutics, Inc.
Grant or award
A—
14.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

5
CC
Cowan ChadChief Scientific Officer
IPSCCentury Therapeutics, Inc.
Tax withholding
F$1,603
1,611 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

5
KM
Krupka Devin MController, PAO
BANDBandwidth Inc.
Option exercise
M—
352 sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

5
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Grant or award
A—
103.1K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

5
KM
Krupka Devin MController, PAO
BANDBandwidth Inc.
Tax withholding
F$1,692
119 sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

5
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Grant or award
A—
171.4K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

5
KM
Krupka Devin MController, PAO
BANDBandwidth Inc.
Option exercise
M—
352 sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

5
OT
O'Connor John TerryGeneral Counsel
GSHDGoosehead Insurance, Inc.
Grant or award
A—
15.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

5
OS
Olsson ShawnChief Commercial Officer
LENZLENZ Therapeutics, Inc.
Grant or award
A—
84.2K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

3
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Derivative conversion · 10b5-1 plan
C—
2,409 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

3
SC
Spice Adam C.Chief Financial Officer
RKLBRocket Lab Corp
Option exercise · 10b5-1 plan
M—
731.3K sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

3
LM
Lin MarkEVP and CFO
SMTCSEMTECH CORP
Option exercise · 10b5-1 plan
M—
3,164 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence